2026 ICD-10-CM Diagnosis Code D68.8Other specified coagulation defects

ICD-10-CM CodesD50–D89D65-D69D68

ICD-10-CM D68.8
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D68.8 is a billable ICD-10-CM diagnosis code for other specified coagulation defects. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.

Code Identity

ICD-10-CM Code
D68.8
Billable Status
Yes — Valid for Submission
Code Describes
Other specified coagulation defects
Short Description
Other specified coagulation defects
Same as the full description in the CMS dataset.
Parent Code
Other coagulation defects

Code Classification

ChapterD50–D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
SectionD65-D69Coagulation defects, purpura and other hemorrhagic conditions
CategoryD68Other coagulation defects
This CodeD68.8Other specified coagulation defects

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 deficiency
  • Abnormal fibrinolysis
  • Acquired coagulation disorder
  • Acquired coagulation factor inhibitor disorder
  • Acquired fibrinogen abnormality
  • Acquired hypofibrinogenemia
  • Acquired hypoplasminogenemia
  • Acquired inhibitor of coagulation
  • Afibrinogenemia
  • Alpha-2-antiplasmin deficiency
  • Anticoagulant excess without bleeding
  • Anti-factor II disorder
  • Antiprothrombin disorder
  • Bleeding disorder due to calcium and DAG-regulated guanine exchange factor-1 deficiency
  • Blood coagulation disorder with impaired clot retraction time
  • Blood coagulation disorder with prolonged bleeding time
  • Blood coagulation disorder with prolonged coagulation time
  • Blood coagulation disorder with shortened bleeding time
  • Blood coagulation disorder with shortened coagulation time
  • Blood coagulation disorder, categorized by value of screening test
  • Body skin hyperlaxity due to vitamin K dependent coagulation factor deficiency
  • Combined coagulation factor deficiency
  • Congenital alpha-2-antiplasmin deficiency
  • Congenital fibrinogen abnormality
  • Congenital hypofibrinogenemia
  • Decreased fibrinolysis
  • Defect of purinergic receptor p2y G protein-coupled 12
  • Deficiency of naturally occurring coagulation factor inhibitor
  • Disorder involving the fibrinolytic system
  • Drug-induced coagulation inhibitor disorder
  • East Texas bleeding disorder
  • Factor IX inhibitor disorder
  • Factor V short isoforms related bleeding disorder
  • Factor XI inhibitor disorder
  • Familial multiple factor deficiency syndrome
  • Familial multiple factor deficiency syndrome, type I
  • Familial multiple factor deficiency syndrome, type II
  • Familial multiple factor deficiency syndrome, type III
  • Familial multiple factor deficiency syndrome, type IV
  • Familial multiple factor deficiency syndrome, type V
  • Familial multiple factor deficiency syndrome, type VI
  • Familial thrombomodulin anomalies
  • Fibrinolytic bleeding syndrome
  • Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation
  • Hereditary combined coagulation factor deficiency
  • Hereditary factor I deficiency disease
  • Hereditary hypoplasminogenemia
  • Hypofibrinogenemia
  • Hypoplasminogenemia
  • Pseudo von Willebrand disease
  • Thrombomodulin-related bleeding disorder

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • COVID-19 associated coagulopathy

Code Also

  • , if applicable, associated condition

Type 1 Excludes

  • hemorrhagic disease of newborn P53

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Afibrinogenemia
    • Defect, defective
      • coagulation (factor)
        • with
          • COVID-19 associated coagulopathy
    • Defect, defective
      • coagulation (factor)
        • specified type NEC
    • Deficiency, deficient
      • coagulation NOS
        • specified NEC
    • Deficiency, deficient
      • factor
        • multiple (congenital)
    • Fibrinogenopenia
    • Hypofibrinogenemia

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR BLD006
Coagulation and hemorrhagic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Afibrinogenemia

    a deficiency or absence of fibrinogen in the blood.
  • Fibrinogen

    plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides a and b, the proteolytic action of other enzymes yields different fibrinogen degradation products.
  • Afibrinogenemia

    a blood coagulation disorder characterized by the complete absence of fibrinogen in the blood, resulting in bleeding.

Patient EducationClinical

Bleeding Disorders

Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D68.8 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
286.9 Coagulat defect NEC/NOS
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D68.8Overview

Is D68.8 (Other coagulation defects) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other specified coagulation defects on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of D68.8?

Under the General Equivalence Mappings, other specified coagulation defects converts to ICD-9-CM 286.9 (coagulat defect NEC/NOS). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.